News Detail

A new international study led by Dr. Tobias Stöger (LHI, Helmholtz Munich) and Prof. Herbert Schiller (PRM, Helmholtz Munich) has provided new insights into how inhaled nanomaterials spark inflammatory responses in the lungs.

Research into a novel form of cell death is entering its next phase and could soon help reduce complications after heart attacks or organ transplants. The Federal Ministry of Research, Technology, and Space (BMFTR) is providing continued support for…

Futuristic medical concept with red human lungs

The European Respiratory Society (ERS) and COPD-iNET Research Symposium in Prague brought together more than 120 clinicians, researchers, and patient advocates to address one of the most pressing challenges in respiratory medicine: Chronic…

World COPD Day aims to raise awareness, share knowledge, and promote action to reduce the global burden of chronic obstructive pulmonary disease (COPD). Helmholtz Munich is driving progress in these efforts, with pioneering research on new…

When nanoparticles enter the lungs, the immune system reacts within minutes. Researchers from the Institute of Lung Health and Immunity (LHI) at Helmholtz Munich have now revealed how alveolar macrophages – immune cells located in the lung’s air sacs…

Helmholtz Munich has secured funding in the Helmholtz Association’s first-ever “UNLOCK” call for AI benchmarking. The LHI is proud to include its AI and lung research expertise in two approved projects:

All News

ToxAtlas: How Inhaled Nanomaterials Trigger Lung Inflammation at the Cellular Level

Funding for Cell Death Research Extended

ERS–COPD-iNET: International Research Symposium Highlights Opportunities for Early Intervention in COPD

World COPD Day 2025

How Lung Cells Initiate the Immune Response to Nanoparticles

Institute of Lung Health and Immunity and Helmholtz Munich to Advance AI Benchmarking With Two Newly Funded Projects